Related Experiment Video
Updated: Aug 10, 2025

06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.9K
Case report: Clinical lycanthropy in Huntington's disease
Nick Medford1, Natasha Sigala2
1Department of Neuropsychiatry, South London and Maudsley NHS Foundation Trust, London, United Kingdom.
Frontiers in Psychiatry
|February 13, 2023
Summary
This case study details a Huntington's disease (HD) patient who developed clinical lycanthropy psychosis. Clozapine remarkably improved his werewolf delusion and choreiform movements.
Area of Science:
- Neurology
- Psychiatry
Background:
- Huntington's disease (HD) is a neurodegenerative disorder.
- Clinical lycanthropy is a rare psychiatric condition involving a delusion of being an animal.
Observation:
- A patient with Huntington's disease developed a two-year history of anxiety and obsessional preoccupations.
- This progressed to psychosis with clinical lycanthropy (delusion of being a werewolf).
- Standard antidepressants and antipsychotics were ineffective.
Findings:
- Clozapine treatment led to remarkable improvement in the patient's psychotic symptoms and delusional beliefs.
- The patient's choreiform movement disorder also showed improvement as his mental state stabilized.
- This is the first reported case of clinical lycanthropy in a patient with Huntington's disease.
Implications:
- This case highlights a potential therapeutic role for Clozapine in managing complex psychiatric manifestations of HD.
- It underscores the importance of considering neurological conditions in atypical presentations of clinical lycanthropy.
- The case prompts further investigation into the interplay of cultural factors, somatosensory processing, and self-perception in delusional disorders.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
641
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
641
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Parkinson's Disease: Treatment
330
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
330
Cardiomyopathy III: Hypertrophic Cardiomyopathy
21
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21

